Hôpital D'Enfants

Vandœuvre-lès-Nancy 54511

0 studies enrolling now · 2 studies all time

What they study most

Arthritis, Juvenile, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Studies at this site

• A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis — Completed
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed